Integer (NYSE:ITGR) PT Raised to $145.00 at Bank of America

Integer (NYSE:ITGR) had its price objective upped by Bank of America from $135.00 to $145.00 in a research report issued to clients and investors on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the medical equipment provider’s stock. Bank of America‘s price target indicates a potential upside of 12.40% from the company’s previous close.

A number of other equities analysts have also commented on the company. Truist Financial raised their price objective on Integer from $137.00 to $145.00 and gave the stock a “buy” rating in a research note on Tuesday. Oppenheimer started coverage on Integer in a research note on Tuesday, July 16th. They issued an “outperform” rating and a $135.00 price target on the stock. Finally, Benchmark reiterated a “buy” rating and issued a $130.00 price target on shares of Integer in a research note on Friday, August 2nd. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $136.43.

Integer Price Performance

Integer stock traded down $1.00 during mid-day trading on Tuesday, reaching $129.00. 48,694 shares of the company were exchanged, compared to its average volume of 316,194. The company has a fifty day simple moving average of $123.35 and a 200-day simple moving average of $119.22. Integer has a 12 month low of $69.40 and a 12 month high of $131.87. The company has a debt-to-equity ratio of 0.73, a current ratio of 3.29 and a quick ratio of 1.96. The firm has a market cap of $4.32 billion, a PE ratio of 44.76, a PEG ratio of 1.87 and a beta of 1.09.

Integer (NYSE:ITGR) last posted its quarterly earnings data on Thursday, July 25th. The medical equipment provider reported $1.30 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.06. Integer had a return on equity of 11.48% and a net margin of 6.31%. The firm had revenue of $436.20 million for the quarter, compared to analyst estimates of $437.00 million. During the same quarter last year, the company earned $1.14 EPS. The company’s revenue was up 9.0% on a year-over-year basis. As a group, equities research analysts expect that Integer will post 5.31 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Jean M. Hobby sold 11,960 shares of the business’s stock in a transaction on Wednesday, July 31st. The stock was sold at an average price of $119.66, for a total transaction of $1,431,133.60. Following the sale, the director now owns 2,280 shares in the company, valued at approximately $272,824.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 2.00% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Integer

Hedge funds and other institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. increased its stake in shares of Integer by 0.6% in the first quarter. Vanguard Group Inc. now owns 3,826,088 shares of the medical equipment provider’s stock valued at $446,428,000 after buying an additional 23,382 shares during the period. Earnest Partners LLC increased its stake in shares of Integer by 3.2% in the second quarter. Earnest Partners LLC now owns 1,208,319 shares of the medical equipment provider’s stock valued at $139,911,000 after buying an additional 37,340 shares during the period. Congress Asset Management Co. MA increased its stake in shares of Integer by 7.5% in the first quarter. Congress Asset Management Co. MA now owns 453,260 shares of the medical equipment provider’s stock valued at $52,886,000 after buying an additional 31,736 shares during the period. Driehaus Capital Management LLC increased its stake in shares of Integer by 62.5% in the second quarter. Driehaus Capital Management LLC now owns 353,052 shares of the medical equipment provider’s stock valued at $40,880,000 after buying an additional 135,750 shares during the period. Finally, Tributary Capital Management LLC increased its stake in shares of Integer by 0.3% in the second quarter. Tributary Capital Management LLC now owns 286,449 shares of the medical equipment provider’s stock valued at $33,168,000 after buying an additional 772 shares during the period. Institutional investors own 99.29% of the company’s stock.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.